We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Update about the developing role of biosimilar medicines in the NHS in England and the safe, effective and consistent use of biosimilar medicines.
Information and documents on Public Health England’s review of the evidence for dependence on, and withdrawal from, prescribed medicines.
Apply for an import certificate to import a medicinal product into the UK for veterinary use.
The CMU is part of the Medicine, Pharmacy and Industry Group of DHSC which looks at supply and procurement in hospitals.
Legal requirements and good practice guidance for Veterinary Practice Premises Inspections.
The changes will allow pharmacists to spend more time with patients, levelling the playing field between smaller pharmacies and larger chains.
Guidance on naming human medicines, including Braille requirements for the name on the product label.
How veterinary medicines can be advertised.
Information about how to register your homeopathic medicinal product through the Simplified Homeopathic Registration Scheme or the UK Homeopathic National Rules Scheme
Guidance for prescribing vets on the use of the cascade.
Actions that trial sponsors should consider to build resilience into clinical trial design
Links to EU guidance, as it stood immediately before end of transition period.
The actions to take for sourcing medicines in different circumstances.
How to carry out a clinical trial to apply for a marketing authorisation, manage your authorisation and report safety issues.
Safety leaflet on opioid medicines to help patients and their families reduce the risks of harm.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Guidance for veterinary medicines manufacturers and wholesale dealers in GB on selling and supplying products placed on the EU and UK markets before 1 January 2021 and the evidence you may need to provide.
Details of the Yellow Card scheme, which is the system for recording adverse incidents with medicines and medical devices in the UK.
Guidance following recommendations from the Commission on Human Medicines.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).